Literature DB >> 8610621

Lovastatin plus probucol for prevention of restenosis after percutaneous transluminal coronary angioplasty.

J H O'Keefe1, G W Stone, B D McCallister, C Maddex, R Ligon, R L Kacich, J Kahn, P G Cavero, G O Hartzler, B D McCallister.   

Abstract

Combination lovastatin and probucol reduced total cholesterol (27%) and low-density lipoprotein levels (30%), but did not prevent restenosis or clinical events during the first 6 months after percutaneous transluminal coronary angioplasty.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8610621     DOI: 10.1016/s0002-9149(97)89325-3

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  1 in total

1.  Plaque regression and plaque stabilisation in cardiovascular diseases.

Authors:  Tarun Dave; J Ezhilan; Hardik Vasnawala; Vinod Somani
Journal:  Indian J Endocrinol Metab       Date:  2013-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.